NASDAQ: BOLDBoundless Bio Inc Stock Ownership - Who owns Boundless Bio?
Insider buying vs selling
Have Boundless Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Kevin Tang | 10% Owner | 2026-10-27 | 10,707 | $2.40 | $25.70kBuy |
| Kevin Tang | 10% Owner | 2026-10-26 | 9,606 | $2.38 | $22.86kBuy |
| Kevin Tang | 10% Owner | 2026-10-23 | 6,234 | $2.38 | $14.84kBuy |
| Kevin Tang | 10% Owner | 2026-10-22 | 5,800 | $2.40 | $13.92kBuy |
| Kevin Tang | 10% Owner | 2026-10-20 | 220 | $2.37 | $521.40Buy |
| Kevin Tang | 10% Owner | 2026-10-19 | 12,790 | $2.34 | $29.93kBuy |
| Kevin Tang | 10% Owner | 2026-10-19 | 18,279 | $2.33 | $42.59kBuy |
| Kevin Tang | 10% Owner | 2026-10-16 | 118,185 | $2.34 | $276.55kBuy |
| Kevin Tang | 10% Owner | 2026-08-26 | 18,300 | $2.97 | $54.35kSell |
| Kevin Tang | 10% Owner | 2026-07-21 | 2,975 | $2.44 | $7.26kBuy |
BOLD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BOLD insiders and whales buy or sell their stock.
BOLD Shareholders
What type of owners hold Boundless Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Kevin Tang | 37.70% | 8,575,046 | $21.44M | Insider |
| Keith Crandell | 5.20% | 1,181,766 | $2.95M | Insider |
| Kristina Burow | 5.20% | 1,181,766 | $2.95M | Insider |
| Arch Venture Fund IX LP | 5.20% | 1,181,766 | $2.95M | Insider |
| Jonathan E. Lim | 2.87% | 653,479 | $1.63M | Insider |
| Wellington Biomedical Innovation Master Investors Cayman I LP | 2.45% | 556,233 | $1.39M | Insider |
| Ra Capital Management LP | 1.30% | 295,844 | $739.61k | Insider |
| Zachary Hornby | 1.13% | 256,410 | $641.03k | Insider |
| Christian Hassig | 0.11% | 25,641 | $64.10k | Insider |
| Archve | 0.01% | 2,694 | $6.74k | Institution |
BOLD vs Biotech Stocks
Boundless Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.